Nourishing Bonds: Lutein's Role in Maternal and Children’s Wellness

Compelled by curiosity and a passion for innovation, we uncover the significance of lutein in maternal and children nutrition. Lutein, a crucial nutrient for both maternal health and infant development, has garnered significant attention in recent years. From its role in visual and cognitive health to its natural presence in breast milk, lutein plays a vital part in nurturing both mom and baby. In this blog, we delve into the early days of lutein research, its impact on infant development, and why FloraGLO? Lutein stands as a trusted ingredient for supplement manufacturers aiming to support maternal and children’s health.

Understanding the Role of Lutein

Lutein and zeaxanthin, found abundantly in dark green leafy vegetables, egg yolk, and other dietary sources, serve essential functions in the human body. These carotenoids are known for their ability to absorb short-wave blue light, act as antioxidants, reduce inflammatory markers, and stabilize membrane integrity, particularly in light-exposed organs like the eyes and skin, as well as in high metabolically active areas such as the brain.(1-4)

Early Development and Maternal Transfer

Research suggests that lutein and zeaxanthin are essential during pregnancy and breastfeeding. Maternal plasma concentrations of these carotenoids increase during gestation(5), being provided ?to the developing fetus, furthermore their preferential transfer through breast milk and deposition in the baby eye and brain(6-9) underscores their importance in early visual and cognitive development. Studies have shown higher levels of lutein and zeaxanthin in breastfed infants compared to those fed with formula, emphasizing the significance of maternal intake.(10-11)

Impact on Eye and Brain Health

During infancy, lutein becomes the dominant carotenoid in the retina and brain, supporting both visual acuity and cognitive function.(12-13) Premature infants, in particular, benefit from lutein supplementation, as they often exhibit lower levels of this essential nutrient compared to full-term infants.(14-15) Furthermore, observational studies have linked maternal lutein intakes during pregnancy or lutein levels in breast milk? to improved visual and cognitive development in infant and children.(16-20)

Lutein Supplementation and Clinical Evidence

FloraGLO Lutein, sourced from tagetes erecta, marigold flowers and naturally containing zeaxanthin, has been extensively studied for its efficacy and safety at all ages and stages. Intervention studies have shown its ability to increase lutein levels in maternal serum, breast milk, and infant plasma, highlighting its responsiveness and bioavailability.(8) Moreover, supplementation with FloraGLO Lutein is safe and has shown promising results in reducing oxidative stress in newborns and supporting visual performance in infant and children.(21-30)

The Importance of Dietary Sources

Given that lutein and zeaxanthin cannot be synthesized by the body, ensuring adequate intake through dietary sources is essential,(31-32) especially during critical stages like pregnancy, breastfeeding, and childhood. Despite the established benefits of these carotenoids, studies indicate that the average intake among children and women of childbearing age falls well below the levels found to be beneficial in these populations , underscoring the need for supplementation.(33)

Trusted Source: FloraGLO Lutein

FloraGLO Lutein stands as the gold standard in lutein supplementation, with a legacy of safety, efficacy, and scientific validation. Supported by over 100 peer-reviewed articles(34), including landmark studies like the AREDS2(35), FloraGLO Lutein has revolutionized the field of lutein research. Its safety has been affirmed by regulatory bodies worldwide, and its science validated in 8?peer-reviewed publications in maternal and infants health(36-38) making it the preferred choice for supplement manufacturers aiming to enhance maternal and infant health.

Conclusion

In conclusion, lutein plays a pivotal role in maternal and children’s health, influencing visual and cognitive development from the earliest stages of life. Compelled by curiosity and driven by a commitment to innovation, Kemin offers FloraGLO Lutein - the flagship Lutein solution in our nutritional carotenoid portfolio. Developed through a unique world-class breeding program with patented marigold flowers, Kemin’s nutritional carotenoids set the standard for quality and efficacy for all ages and stages of life.?

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region-specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region-specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.

References:

1. Wooten BR, Hammond BR. Macular pigment: Influences on visual acuity and visibility. Prog Retin Eye Res. 2002;21(2):225–40.
2. Krinsky NI, Landrum JT, Bone RA. Biologic mechanism of the protective role of Lutein and Zeaxanthin in the Eye. Annu Rev Nutr. 2003;23:171–201.
3. Kritchevsky SB, Bush AJ, Pahor M, Gross MD. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol. 2000;152(11):1065–71.
4. Gruszecki WI, Strza?ka K. Carotenoids as modulators of lipid membrane physical properties. Biochim Biophys Acta - Mol Basis Dis. 2005;1740(2):108–15
5. Oostenbrug GS, Mensink RP, Al MDM, van Houwelingen AC, Hornstra G. Maternal and neonatal plasma antioxidant levels in normal pregnancy, and the relationship with fatty acid unsaturation. Br J Nutr. 1998;80(1):67–73.
6. Khachik F, Spangler CJ, Smith JC, Canfield LM, Steck A, Pfander H. Identification, Quantification, and Relative Concentrations of Carotenoids and Their Metabolites in Human Milk and Serum. Anal Chem. 1997 May 15;69(10):1873–81.
7. Patton S, Canfield LM, Huston GE, Ferris AM, Jensen RG. Carotenoids of human colostrum. Lipids. 1990;25(3):159–65.
8. Sherry CL, Oliver JS, Renzi LM, Marriage BJ. Lutein Supplementation Increases Breast Milk and Plasma Lutein Concentrations in Lactating Women and Infant Plasma Concentrations but Does Not Affect Other Carotenoids. J Nutr. 2014;144(8):1256–63.
9. Cena H, Castellazzi AM, Pietri A, Roggi C, Turconi G. Lutein concentration in human milk during early lactation and its relationship with dietary lutein intake. Public Health Nutr. 2009;12(10):1878–84.
10. Neuringer M, Bone RA, Jeffrey B, Bettler J, Zimmer JP, Wallace P, et al. Lutein in Breastmilk and Infant Formula: Effects on Serum Lutein, Macular Pigment and Visual Function. Invest Ophthalmol Vis Sci [Internet]. 2009;50(13):1707. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2364128
11. Liu Z, Meyers KJ, Johnson EJ, Snodderly M, Tinker L, Wallace R, et al. Exposure to Lutein in Infancy via Breast Milk and Later Life Macular Pigment Optical Density. Investig Ophthalmol Vis Sci [Internet]. 2015;56(7):192. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2331661 https://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=615917349
12. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Investig Ophthalmol Vis Sci. 1988;29(6):843–9.
13. ?Vishwanathan R, Kuchan MJ, Sen S, Johnson EJ. Lutein is the predominant carotenoid in infant brain: Preterm infants have decreased concentrations of brain carotenoids. J Pediatr Gastroenterol Nutr. 2014;59(5):659–65.
14. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Investig Ophthalmol Vis Sci. 1988;29(6):843–9
15. Bernstein PS, Sharifzadeh M, Liu A, Ermakov I, Nelson K, Sheng X, et al. Blue-light reflectance imaging of macular pigment in infants and children. Investig Ophthalmol Vis Sci. 2013;54(6):4034–40
16. Neuringer M, Bone RA, Jeffrey B, Bettler J, Zimmer JP, Wallace P, et al. Lutein in Breastmilk and Infant Formula: Effects on Serum Lutein, Macular Pigment and Visual Function. Invest Ophthalmol Vis Sci [Internet]. 2009;50(13):1707. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2364128
17. Liu Z, Meyers KJ, Johnson EJ, Snodderly M, Tinker L, Wallace R, et al. Exposure to Lutein in Infancy via Breast Milk and Later Life Macular Pigment Optical Density. Investig Ophthalmol Vis Sci [Internet]. 2015;56(7):192. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2331661 https://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=615917349
18. Lai, J.S.; Veetil, V.O.; Lanca, C.; Lee, B.L.; Godfrey, K.M.; Gluckman, P.D.; Shek, L.P.; Yap, F.; Tan, K.H.; Chong, Y.S.; et al. Maternal Lutein and Zeaxanthin Concentrations in Relation to Offspring Visual Acuity at 3 Years of Age: The GUSTO Study. Nutrients 2020, 12, 1–11, doi:10.3390/nu12020274
19. Mahmassani, H.A.; Switkowski, K.M.; Scott, T.M.; Johnson, E.J.; Rifas-Shiman, S.L.; Oken, E.; Jacques, P.F. Maternal Intake of Lutein and Zeaxanthin during Pregnancy Is Positively Associated with Offspring Verbal Intelligence and Behavior Regulation in Mid-Childhood in the Project Viva Cohort. J. Nutr. 2021, 151, 615–627, doi:10.1093/jn/nxaa348.
20. Cheatham, C.L.; Sheppard, K.W. Synergistic Effects of Human Milk Nutrients in the Support of Infant Recognition Memory: An Observational Study. Nutrients 2015, 7, 9079–9095, doi:10.3390/nu7115452.
21. Capeding R, Gepanayao CP, Calimon N, Lebumfacil J, Davis AM, Stouffer N, et al. Lutein-fortified infant formula fed to healthy term infants: Evaluation of growth effects and safety. Nutr J. 2010;9(1):1–9.
22. Mackey AD, Albrecht D, Oliver J, Williams T, Long AC, Price PT. Plasma carotenoid concentrations of infants are increased by feeding a milk-based infant formula supplemented with carotenoids. J Sci Food Agric. 2013;93(8):1945–52.
23. Bettler J, Zimmer JP, Neuringer M, Derusso PA. Serum lutein concentrations in healthy term infants fed human milk or infant formula with lutein. Eur J Nutr. 2010;49(1):45–51.
24. Perrone S, Longini M, Marzocchi B, Picardi A, Bellieni C V., Proietti F, et al. Effects of Lutein on Oxidative Stress in the Term Newborn: A Pilot Study. Neonatology [Internet]. 2010;97(1):36–40. Available from: https://www.karger.com/Article/FullText/227291
25. Perrone S, Tei M, Longini M, Santacroce A, Turrisi G, Proietti F, et al. Lipid and protein oxidation in newborn infants after lutein administration. Oxid Med Cell Longev. 2014;2014.
26. Systemic Effects of Prenatal Carotenoid Supplementation in the Mother and her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial–Report Number 1
27. Gorka, J.E., Addo, E.K., Allman, S., Harrison, D.Y., Brintz, B., Sharifzadeh, M., Hartnett, M.E. and Bernstein, P.S., 2023. The Effects of Prenatal Carotenoid Supplementation on Infant Foveal Maturity: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Trial.?Investigative Ophthalmology & Visual Science,?64(8), pp.5203-5203.
28. Bernstein, P.S., Addo, E.K., Allman, S., Arunkumar, R. and Varner, M., 2023. Maternal Ocular and Systemic Effects of Prenatal Carotenoid Supplementation in the Lutein and Zeaxanthin in Pregnancy (L-ZIP) Trial.?Investigative Ophthalmology & Visual Science,?64(8), pp.1417-1417.
29. Rubin, L.P.; Chan, G.M.; Barrett-Reis, B.M.; Fulton, A.B.; Hansen, R.M.; Ashmeade, T.L.; Oliver, J.S.; MacKey, A.D.; Dimmit, R.A.; Hartmann, E.E.; et al. Effect of Carotenoid Supplementation on Plasma Carotenoids, Inflammation and Visual Development in Preterm Infants. J. Perinatol. 2012, 32, 418–424, doi:10.1038/jp.2011.87.
30. Kemin Internal Document TD-18-4987 - Randomized, DBPCP Pilot Study to Evaluate the Effects of Lutein Supplementation on Visual Performance Following Blue Light Exposure in school-aged children
31. USDA-NNCC. Carotenoid Database for U.S. Foods [Internet]. 1998. Available from: www.usda.gov
32. Stahl W. Macular carotenoids: lutein and zeaxanthin. Dev Ophthalmol. 2005;38:70–88.
33. ?Johnson EJ, Maras JE, Rasmussen HM, Tucker KL. Intake of lutein and zeaxanthin differ with age, sex, and ethnicity. J Am Diet Assoc [Internet]. 2010;110(9):1357–62. Available from: https://dx.doi.org/10.1016/j.jada.2010.06.009
34. KHTL-017-083
35. AREDS 2 TA-REDS 2 R. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA - J Am Med Assoc. 2013;309(19):2005–15
36. ?JECFA. Lutein from Tagetes erecta. Chemical and Technical Assessment [Internet]. 2004. Available from: https://www.fao.org/fileadmin/templates/agns/pdf/jecfa/cta/63/Lutein.pdf%0A
37. Scientific Opinion of the Panel on Dietetic Products N and A. Safety, bioavailability and suitability of lutein for the particular nutritional use by infants and young children [Internet]. 2008. Available from: https://www.efsa.europa.eu/fr/efsajournal/pub/823
38. GRAS. U.S. Food & Drug Administration, 2004.GRAS Notice Inventory, GRN No. 140, 221 and 390.